Welcome to the L.B. Bohle Maschinen + Verfahren GmbH press center.
Update information about the company is available here; you may also download files and browse through the archives.
Please do not hesitate to contact us should you require further information or would like to make an appointment for an interview or inquiries about the company.
Your contact at the company:
Marketing / Public Relations
Ongoing further development of environmental and energy management.
L.B. Bohle Maschinen + Verfahren GmbH successfully passed the certification of the environmental audition at the end of the last year. The certification is valid for all three facilities. With this audition L.B. Bohle provides the strong focus on quality and the environmentally friendly and energy-efficient production of its products.
Certificate - download
In the pharmaceutical industry, granulation plays a key role in the production of solid dosage forms – particularly due to the pressure of rising costs. Granulation aims to form coarser agglomerates from fine powder. Agglomerates may consist of fixed, dry grains, and each grain is an agglomeration of powder particles of sufficient strength. Granulates can be used directly as pharmaceuticals or can serve as an intermediate in the production of tablets or capsules.
L.B. Bohle Maschinen + Verfahren GmbH (Ennigerloh) offers a wide range of granulation solutions. The Bohle portfolio for manufacturing oral solids includes complete production systems as well as stand-alone machines. In addition, the mechanical engineering company specialist has developed and delivered a large number of containment applications for the pharmaceutical and food industries. An introduction to granulation concepts, fields of application and added value for customers is given below.
We Look Forward to Welcoming You at the Following Events:
Successful start at PMEC India: Even at the first day, a huge number of prospects and customers visited the booth of L.B. Bohle to learn more about products and latest innovations.
As a technological leader, L.B. Bohle is well-known as an innovative and reliable machine builder in this fast growing pharma market.
Topics of the current issue:
- L.B. Bohle shines with QbCOn® 1 at ACHEMA
- Three continuous processes in combined in one system - QbCon® 1 sets new standards in the pharmaceutical industry
- b.sure® 1- A new platform for all PLCs by L.B. Bohle
- ISO certification successfully renewed
- Continuous manufacturing in the pharmaceutical industry - Workshop in September 2018
- L.B. Bohle at training fair "Mach Mit"
- Customer presence with even more power: L.B. Bohle joins Propack® as new sales partner
Read the current issue
The 2nd Workshop on Continuous Pharmaceutical Manufacturing was a huge success. More than 40 particpants from all over the world informed tehmselves about current trends and strategies.
Further impressions of this event.
Continuous Pharmaceutical Manufacturing: more than 40 experts from Asia, Europe, South and North America at the technical symposium.
For two days in the mid of September, Ennigerloh was the place to be for experts and users in the pharmaceutical industry doing research in the area of continuous manufacturing: They accepted the invitation of L.B. Bohle Maschinen + Verfahren GmbH to the “2nd Continuous Pharmaceutical Manufacturing Symposium“ to discuss the processes of the future. “We are in constant exchange with scientists are at the technological forefront when it comes to continuous processes for the pharmaceutical industry," reports Tim Remmert, Managing Director.
“For pharmaceutical manufacturers, continuous manufacturing means shorter time to market, more flexible production even of small batches and highest precision and quality due to comprehensive process monitoring and control,” added Thorsten Wesselmann, Technical Director. This saves time and costs for our customers in the pharmaceutical industry. More than 40 guests from Asia, South America, North America and, last but not least, Europe exchanged views on the current state of developments and discussed future steps at the symposium. At the globally unique Technology Center the participants had the chance to get a first-hand impression of the sensor technology measurement, analysis and control technology in practical application.
Download the program and agenda of our exclusive 3-day practical hands-on workshop by leading experts with industrial, academial and regulatory experience.
Program and Agenda!
In the pharmaceutical industry, one term is becoming increasingly important: containment. It describes the process of containing a substance within a defined space, a method that is suitable for protecting operators and the environment in case of high toxicity and product reactivity. At the same time, containment prevents dust, gases or vapours from being released into the environment and contaminating the product.
More than 60 percent of pharmaceutical products are produced as tablets, capsules, lozenges or similar solids. Especially in new products the active pharmaceutical ingredients (APIs) are becoming increasingly more potent. In some markets, the segment for high potency active pharmaceutical ingredients (HPAIs) is growing in the double-digit range, especially driven by oncology medication.
In addition to requirements set by manufacturing guidelines, it is essential that the product is safe for the machine operator and, of course, for the patient. As a result, machine manufacturers such as L.B. Bohle are faced with new challenges in all toxicity classes in which customers want to use plants and processes. In 2017, numerous customers with special specifications turned to the independent medium-sized family-owned company requesting, among other things, containment solutions for film coating applications and a dry granulation process.
L.B. Bohle introduces the process tracking app b.sure® at ACHEMA. b.sure® is a monitoring application that keeps track of your process at all times. In comparison to other solutions on the market that operate via cloud, b.sure® keeps the data in the company.
b.sure® is web-based and can be opened either on the respective device or via the sent email.